Abstract
The binding of L-tryptophan (L-Trp) and hesperidin (HES) was investigated by UV, fluorescence, synchronous fluorescence, time-resolved fluorescence, Fourier transform infrared (FTIR) spectroscopies, FRET, antibacterial activity, anticancer activity and molecular docking study. The flavonoid glycoside known as hesperidin has been shown to have therapeutic properties for a variety of disorders, including cancer diseases. Its low solubility and bioavailability cause it to be little absorbed, which means that a delivery mechanism is necessary in order for it to reach its therapeutic goal. Fluorescence data revealed that the fluorescence quenching mechanisms of L Trp by hesperidin are all static quenching procedures. Synchronous fluorescence spectroscopy shows the interaction between hesperidin and L-Trp changes the hydrophobicity of the microenvironment of tryptophan (Trp) residues. The anticancer activity effect of hesperidin and L-Trp on human cervical cancer cell lines was assessed using MTT and crystal violet assays.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
